BioNTech (BNTX) PT Lowered to $158 at Canaccord

May 6, 2026 6:51 AM

Canaccord analyst William Maughan lowered the price target on BioNTech (NASDAQ: BNTX) to $158.00 (from $171.00) while maintaining a Buy rating.

No results found